Notice of Correction to Key Dates in RFA-CA-23-015, Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Notice Number:
NOT-CA-23-072

Key Dates

Release Date:

June 16, 2023

Related Announcements

  • December 22, 2022 - Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional). See NOFO RFA-CA-23-015.

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Key Dates in RFA-CA-23-015, Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional).

Part 1. Overview Information, Key Dates

Currently reads:

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
June 13, 2023June 13, 2023Not ApplicableOctober 2024January 2024April 2024
November 17, 2023November 17, 2023Not ApplicableMarch 2024May 2024July 2024

Corrected to read (in bold italics):

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
June 13, 2023June 13, 2023Not ApplicableOctober 2023January 2024April 2024
November 17, 2023November 17, 2023Not ApplicableMarch 2024May 2024July 2024

All other aspects of RFA-CA-23-015 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Juli Klemm, Ph.D.
National Cancer Institute (NCI)
Telephone: 202-853-7889
Email: [email protected]

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]

Financial/Grants Management Contact(s)

Sean Hine
National Cancer Institute (NCI)
Telephone: 240-276-6291
E-mail: [email protected]